Earnings NewsHealthcareEidos Therapeutics EPS of $0.18Oct. 31, 2019 4:56 PM ETEidos Therapeutics, Inc. (EIDX) StockEIDXBy: Pranav Ghumatkar, SA News Editor Eidos Therapeutics (NASDAQ:EIDX): Q3 EPS of $0.18 may not be comparable to consensus of -$0.27. Revenue of $26.69M beats by $24.61M. Press Release Recommended For YouMore Trending NewsSee More »Related StocksSymbolLast Price% ChgEIDX--Eidos Therapeutics, Inc.Trending AnalysisTrending News